A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer
Clinical trial NCT04197999 · TERMINATED
Trial details
- NCT number
- NCT04197999
- Sponsor
- GlycoMimetics Incorporated
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2021-08-25
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.